Cloned (Comment) | Organism |
---|---|
recombinant expression of N-terminally His6-tagged NUDT5 in Escherichia coli strain BL21(DE3) | Homo sapiens |
Crystallization (Comment) | Organism |
---|---|
purified recombinant enzyme NUDT5 in complex with inhibitors TH1713 and TH5427, X-ray diffraction structure determination and analysis at 2.2-2.6 A resolution | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | siRNA-mediated knockdown of NUDT5. Following depletion with NUDT5 siRNAs prior to cell lysis, ADPR hydrolysis is markedly attenuated compared to non-targeting siRNA controls. This can be rescued by the addition of recombinant NUDT5 protein | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3,8-trimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | slight inhibition | Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-8-(2-oxa-6-azaspiro[3.3]heptan-6-yl)-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-8-(4-methylpiperazin-1-yl)-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-8-(4-methylpiperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-8-(methylamino)-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-8-(morpholin-4-yl)-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-8-(piperazin-1-yl)-3,7-dihydro-1H-purine-2,6-dione | lead compound, blocks progestin-dependent, PAR-derived nuclear ATP synthesis and subsequent chromatin remodeling, gene regulation and proliferation in breast cancer cells. Inhibitor-enzyme complex structure analysis, overview. TH5427 has no effect on NUDT9-mediated hydrolysis of ADPR, indicating discrimination amongst ADP-ribose hydrolases | Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-8-(piperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-8-(propan-2-yl)-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-8-propyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-8-(4-ethylpiperazin-1-yl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-8-(4-hexylpiperazin-1-yl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-8-(diethylamino)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-8-(dimethylamino)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-8-(ethylsulfanyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-8-methoxy-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-8-[(2-hydroxyethyl)amino]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-8-[4-(2-hydroxyethyl)piperidin-1-yl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-8-[di(prop-2-en-1-yl)amino]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
8-(4-butylpiperazin-1-yl)-7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
8-(azepan-1-yl)-7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
8-(cyclohexylsulfanyl)-7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
8-benzyl-7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
8-bromo-7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
8-chloro-7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | - |
Homo sapiens | |
additional information | small molecule screening, and identification of potent NUDT5 inhibitors, which are optimized to promote maximal NUDT5 cellular target engagement by CETSA. Inhibitors chelerythrine (a PKC inhibitor), LY294002 (a PI3K inhibitor), as well as 4-coumaric acid and flavone have no direct inhibitory effect on NUDT5 activity in the enzyme-coupled malachite green assay | Homo sapiens | |
tert-butyl 4-(7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperazine-1-carboxylate | - |
Homo sapiens |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + D-ribose 5-phosphate | Homo sapiens | - |
diphosphate + ADP-D-ribose | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q9UKK9 | - |
- |
Purification (Comment) | Organism |
---|---|
recombinant N-terminally His6-tagged NUDT5 from Escherichia coli strain BL21(DE3) by nickel affinity chromatography | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
breast cancer cell | - |
Homo sapiens | - |
HeLa cell | - |
Homo sapiens | - |
HL-60 cell | - |
Homo sapiens | - |
T-47D cell | - |
Homo sapiens | - |
U2-OS cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + D-ribose 5-phosphate | - |
Homo sapiens | diphosphate + ADP-D-ribose | - |
? | |
additional information | 8-oxo-dGDP is a poor substrate for enzyme NUDT5 at physiological pH | Homo sapiens | ? | - |
- |
Synonyms | Comment | Organism |
---|---|---|
NUDIX5 | - |
Homo sapiens |
NUDT5 | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
22 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.5 | - |
assay at | Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000029 | - |
pH 7.5, 22°C | Homo sapiens | 7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-8-(piperazin-1-yl)-3,7-dihydro-1H-purine-2,6-dione | |
0.000039 | - |
pH 7.5, 22°C | Homo sapiens | 7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-8-(4-ethylpiperazin-1-yl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | |
0.000054 | - |
pH 7.5, 22°C | Homo sapiens | 8-(4-butylpiperazin-1-yl)-7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione |
General Information | Comment | Organism |
---|---|---|
malfunction | enzyme inhibition by inhibitor TH5427 blocks progestin-dependent, PAR-derived nuclear ATP synthesis and subsequent chromatin remodeling, gene regulation and proliferation in breast cancer cells. Following depletion with NUDT5 siRNAs prior to cell lysis, ADPR hydrolysis is markedly attenuated compared to non-targeting siRNA controls. This can be rescued by the addition of recombinant NUDT5 protein. siRNA-mediated knockdown of NUDT5 alone does not appreciably induce DNA damage signaling in U2-OS cells, as measured by multiple DNA damage markers | Homo sapiens |
metabolism | involvement of NUDT5 in ADP-ribose metabolism, overview | Homo sapiens |
physiological function | enzyme NUDT5 is implicated in ADP-ribose and 8-oxo-guanine metabolism and is a rheostat of hormone-dependent gene regulation and proliferation in breast cancer cells. NUDT5 catalyzes the breakdown of ADPR to ribose-5-phosphate (R5P) and adenosine 5'-monophosphate (AMP), which permits recovery of NAD+ pools after DNA damage and poly(ADPR) polymerase (PARP) activation. In addition, NUDT5 is responsible for the production of PAR-mediated nuclear ATP and, thus, subsequent ATP-dependent chromatin remodeling and gene regulation following progestin or estrogen stimulation in breast cancer cells. NUDT5 activity is critical to elicit nuclear ATP production following hormone stimulation | Homo sapiens |